Amanote Research
Register
Sign In
Active Immunotherapy in Malignant Melanoma.
BMJ
doi 10.1136/bmj.1.6112.579-a
Full Text
Open PDF
Abstract
Available in
full text
Date
March 4, 1978
Authors
M B McIllmurray
W G Reeves
M J Langman
M Deane
M J Embleton
Publisher
BMJ
Related search
Beyond PD-1 Immunotherapy in Malignant Melanoma
Dermatology and Therapy
Dermatology
What Can We Learn Regarding Immunotherapy From Malignant Melanoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Immunological Monitoring in a Controlled Trial of Immunotherapy in Stage IIB Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
Advances in Immunotherapy for Melanoma
BMC Medicine
Medicine
The Focal Adhesion Kinase (P125FAK) Is Constitutively Active in Human Malignant Melanoma
Oncogene
Cancer Research
Genetics
Molecular Biology
Combination Immunotherapy for Melanoma
JAMA Oncology
Cancer Research
Oncology
A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients
Journal of Cancer
Oncology
Hereditary Malignant Melanoma
BMJ
Familial Malignant Melanoma
Plastic and Reconstructive Surgery
Surgery
